Cancer treatment, especially hormonal therapy and therapy directed toward the pelvis, can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. Thus, sexual dysfunction is common in survivors and can cause increased distress and have a significant negative impact on quality of life. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for female sexual problems, including those related to sexual desire, arousal, orgasm, and pain.

  • 1.

    BoberSLVarelaVS. Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol2012;30:37123719.

  • 2.

    DonovanKAThompsonLMHoffeSE. Sexual function in colorectal cancer survivors. Cancer Control2010;17:4451.

  • 3.

    LaumannEOPaikARosenRC. Sexual dysfunction in the United States: prevalence and predictors. JAMA1999;281:537544.

  • 4.

    MorrealeMK. The impact of cancer on sexual function. Adv Psychosom Med2011;31:7282.

  • 5.

    VomvasDIconomouGSoubasiE. Assessment of sexual function in patients with cancer undergoing radiotherapy—a single centre prospective study. Anticancer Res2012;32:657664.

    • Search Google Scholar
    • Export Citation
  • 6.

    ForbatLWhiteIMarshall-LucetteSKellyD. Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer. BJU Int2012;109:98103.

    • Search Google Scholar
    • Export Citation
  • 7.

    WhiteIDAllanHFaithfullS. Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?Br J Cancer2011;105:903910.

    • Search Google Scholar
    • Export Citation
  • 8.

    FinkHAMac DonaldRRutksIR. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med2002;162:13491360.

    • Search Google Scholar
    • Export Citation
  • 9.

    GanzPAGreendaleGAPetersenL. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst2000;92:10541064.

    • Search Google Scholar
    • Export Citation
  • 10.

    NehraA. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc2009;84:139148.

    • Search Google Scholar
    • Export Citation
  • 11.

    MilesCLCandyBJonesL. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev2007:CD005540.

  • 12.

    ACOG Practice Bulletin No. 119: female sexual dysfunction. Obstet Gynecol2011;117:9961007.

  • 13.

    GilbertEUssherJMPerzJ. Sexuality after breast cancer: a review. Maturitas2010;66:397407.

  • 14.

    BarniSMondinR. Sexual dysfunction in treated breast cancer patients. Ann Oncol1997;8:149153.

  • 15.

    FrumovitzMSunCCSchoverLR. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol2005;23:74287436.

  • 16.

    GanzPADesmondKABelinTR. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol1999;17:23712380.

  • 17.

    GanzPARowlandJHDesmondK. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol1998;16:501514.

    • Search Google Scholar
    • Export Citation
  • 18.

    LindauSTGavrilovaNAndersonD. Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms. Gynecol Oncol2007;106:413418.

    • Search Google Scholar
    • Export Citation
  • 19.

    ParkSYBaeDSNamJH. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer2007;110:27162725.

    • Search Google Scholar
    • Export Citation
  • 20.

    RodriguesACTeixeiraRTeixeiraT. Impact of pelvic radiotherapy on female sexuality. Arch Gynecol Obstet2012;285:505514.

  • 21.

    GershensonDMMillerAMChampionVL. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol2007;25:27922797.

    • Search Google Scholar
    • Export Citation
  • 22.

    LammerinkEAde BockGHPrasE. Sexual functioning of cervical cancer survivors: a review with a female perspective. Maturitas2012;72:296304.

    • Search Google Scholar
    • Export Citation
  • 23.

    SyrjalaKLKurlandBFAbramsJR. Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood2008;111:989996.

    • Search Google Scholar
    • Export Citation
  • 24.

    ThygesenKHSchjodtIJardenM. The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant2012;47:716724.

    • Search Google Scholar
    • Export Citation
  • 25.

    WatsonMWheatleyKHarrisonGA. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer1999;86:12311239.

    • Search Google Scholar
    • Export Citation
  • 26.

    ZantomioDGriggAPMacGregorL. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant2006;38:567572.

    • Search Google Scholar
    • Export Citation
  • 27.

    HatzichristouDRosenRCDerogatisLR. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med2010;7:337348.

    • Search Google Scholar
    • Export Citation
  • 28.

    RosenRBrownCHeimanJ. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther2000;26:191208.

    • Search Google Scholar
    • Export Citation
  • 29.

    BaserRELiYCarterJ. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer2012;118:46064618.

  • 30.

    JefferyDDTzengJPKeefeFJ. Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer2009;115:11421153.

    • Search Google Scholar
    • Export Citation
  • 31.

    FlynnPKewFKiselySR. Interventions for psychosexual dysfunction in women treated for gynaecological malignancy. Cochrane Database Syst Rev2009:CD004708.

    • Search Google Scholar
    • Export Citation
  • 32.

    KatzA. Interventions for sexuality after pelvic radiation therapy and gynecological cancer. Cancer J2009;15:4547.

  • 33.

    SuttonKSBoyerSCGoldfingerC. To lube or not to lube: experiences and perceptions of lubricant use in women with and without dyspareunia. J Sex Med2012;9:240250.

    • Search Google Scholar
    • Export Citation
  • 34.

    BigliaNPeanoESgandurraP. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol2010;26:404412.

    • Search Google Scholar
    • Export Citation
  • 35.

    YangEJLimJYRahUWKimYB. Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. Gynecol Oncol2012;125:705711.

    • Search Google Scholar
    • Export Citation
  • 36.

    MilesTJohnsonN. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev2010:CD007291.

  • 37.

    AytonRADarlingGMMurkiesAL. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol1996;103:351358.

    • Search Google Scholar
    • Export Citation
  • 38.

    FooladiEDavisSR. An update on the pharmacological management of female sexual dysfunction. Expert Opin Pharmacother2012;13:21312142.

    • Search Google Scholar
    • Export Citation
  • 39.

    KrychmanML. Vaginal estrogens for the treatment of dyspareunia. J Sex Med2011;8:666674.

  • 40.

    RaghunandanCAgrawalSDubeyP. A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. J Sex Med2010;7:12841290.

    • Search Google Scholar
    • Export Citation
  • 41.

    RossouwJEAndersonGLPrenticeRL. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA2002;288:321333.

    • Search Google Scholar
    • Export Citation
  • 42.

    SucklingJLethabyAKennedyR. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev2006:CD001500.

  • 43.

    DavisonSL. Hypoactive sexual desire disorder. Curr Opin Obstet Gynecol2012;24:215220.

  • 44.

    BrottoLAErskineYCareyM. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecol Oncol2012;125:320325.

    • Search Google Scholar
    • Export Citation
  • 45.

    DuijtsSFvan BeurdenMOldenburgHS. Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol2012;30:41244133.

    • Search Google Scholar
    • Export Citation
  • 46.

    MeanaMJonesS. Developments and trends in sex therapy. Adv Psychosom Med2011;31:5771.

  • 47.

    CavalcantiALBagnoliVRFonsecaAM. Effect of sildenafil on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction. Int J Gynaecol Obstet2008;102:115119.

    • Search Google Scholar
    • Export Citation
  • 48.

    YangCCCaoYYGuanQY. Influence of PDE5 inhibitor on MRI measurement of clitoral volume response in women with FSAD: a feasibility study of a potential technique for evaluating drug response. Int J Impot Res2008;20:105110.

    • Search Google Scholar
    • Export Citation
  • 49.

    AlexanderMSRosenRCSteinbergS. Sildenafil in women with sexual arousal disorder following spinal cord injury. Spinal Cord2011;49:273279.

    • Search Google Scholar
    • Export Citation
  • 50.

    BassonRMcInnesRSmithMD. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med2002;11:367377.

    • Search Google Scholar
    • Export Citation
  • 51.

    BassonRBrottoLA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG2003;110:10141024.

    • Search Google Scholar
    • Export Citation
  • 52.

    BermanJRBermanLATolerSM. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol2003;170:23332338.

    • Search Google Scholar
    • Export Citation
  • 53.

    CarusoSIntelisanoGLupoLAgnelloC. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG2001;108:623628.

    • Search Google Scholar
    • Export Citation
  • 54.

    CarusoSRugoloSAgnelloC. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril2006;85:14961501.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 134 134 9
PDF Downloads 22 22 1
EPUB Downloads 0 0 0